Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The major cardiovascular safety trials The SUSTAIN-6 trial enrolled 3,297 patients with type 2 diabetes and high cardiovascular risk, following them for two years on semaglutide 0.5 mg or 1.0 mg weekly versus placebo
Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials
2016 Jan 1 [cited 2025 Apr 2];67(1):13342
Frequently asked questions What is retatrutide (LY3437943) in research terms
US$ 26.05
US$ 27.09
US$ 25.40
US$ 29.33
US$ 29.14
US$ 25.93
US$ 23.44
US$ 25.79
US$ 21.59
